- Report
- March 2024
- 198 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 283 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- October 2023
- 190 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- August 2023
- 113 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- June 2023
- 139 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- January 2024
- 287 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- January 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2021
- 245 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Report
- February 2023
- 130 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- February 2023
- 130 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- August 2022
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- August 2020
- 112 Pages
Global
From €4102EUR$4,250USD£3,519GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- August 2022
- 76 Pages
Vietnam
From €3378EUR$3,500USD£2,898GBP
- Report
- August 2022
Global
From €1052EUR$1,090USD£902GBP
- Report
- February 2021
Global
From €2857EUR$2,960USD£2,451GBP
- Drug Pipelines
- November 2020
- 419 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- September 2023
- 69 Pages
China
From €1737EUR$1,800USD£1,490GBP
The Tuberculosis Drug market is a subset of the larger Respiratory Drug market. It is composed of drugs used to treat tuberculosis, a bacterial infection that affects the lungs and other parts of the body. These drugs are typically antibiotics, such as isoniazid, rifampicin, and ethambutol, and are used in combination to treat the infection. The drugs are usually taken for a period of six to nine months, and are often used in combination with other treatments, such as surgery or chemotherapy.
The Tuberculosis Drug market is highly competitive, with many companies offering different combinations of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Merck, and Novartis. Other companies, such as Cipla, Lupin, and Sun Pharmaceuticals, also offer a range of tuberculosis drugs. Show Less Read more